735 related articles for article (PubMed ID: 19272490)
1. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.
Wald DS; Law M; Morris JK; Bestwick JP; Wald NJ
Am J Med; 2009 Mar; 122(3):290-300. PubMed ID: 19272490
[TBL] [Abstract][Full Text] [Related]
2. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
3. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.
Lv Y; Zou Z; Chen GM; Jia HX; Zhong J; Fang WW
Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032
[TBL] [Abstract][Full Text] [Related]
4. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.
Law MR; Wald NJ; Morris JK; Jordan RE
BMJ; 2003 Jun; 326(7404):1427. PubMed ID: 12829555
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
6. Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24,000 participants.
Law M; Morris JK; Jordan R; Wald N
Circulation; 2005 Oct; 112(15):2301-6. PubMed ID: 16216977
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
8. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
11. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials.
Staessen JA; Li Y; Thijs L; Wang JG
Hypertens Res; 2005 May; 28(5):385-407. PubMed ID: 16156503
[TBL] [Abstract][Full Text] [Related]
13. Do ancillary properties of antihypertensive drugs explain the outcome results of recent trials?
Staessen JA; Wang J
J Nephrol; 2002; 15(4):422-7. PubMed ID: 12243374
[TBL] [Abstract][Full Text] [Related]
14. Does combination therapy with a calcium channel blocker and an ACE inhibitor have additive effects on blood pressure reduction?
Edelman DA; Paul RA
Int J Clin Pract; 2000 Mar; 54(2):105-9. PubMed ID: 10824365
[TBL] [Abstract][Full Text] [Related]
15. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.
Law MR; Morris JK; Wald NJ
BMJ; 2009 May; 338():b1665. PubMed ID: 19454737
[TBL] [Abstract][Full Text] [Related]
16. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice.
Cicero AF; Gerocarni B; Rosticci M; Borghi C
Clin Exp Hypertens; 2012; 34(2):113-7. PubMed ID: 21967031
[TBL] [Abstract][Full Text] [Related]
18. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
[TBL] [Abstract][Full Text] [Related]
19. When antihypertensive monotherapy fails: fixed-dose combination therapy.
Weir MR
South Med J; 2000 Jun; 93(6):548-56. PubMed ID: 10881767
[TBL] [Abstract][Full Text] [Related]
20. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension].
Widimský J
Vnitr Lek; 2009 Feb; 55(2):123-30. PubMed ID: 19348394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
